Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats.
Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats.
复制标题
DOI:
10.1016/j.urology.2009.12.013
复制
发表时间:
2010-04
期刊:
影响因子:
2.1
通讯作者:
Yoshimura N
中科院分区:
文献类型:
--
作者:
Matsumoto Y;Miyazato M;Furuta A;Torimoto K;Hirao Y;Chancellor MB;Yoshimura N
It has been proposed that the urothelium modulates the activity of bladder afferent pathways. However, the differential roles of muscarinic acetylcholine receptor (mAChR) subtypes in local bladder afferent activation remain unclear. We investigated the effects of various mAChR antagonists including selective M2 and M3 mAChR antagonists on bladder overactivity. Cystometry was performed in urethane anesthetized female rats. We examined the effects of intravesical administration of antimuscarinic agents (non-selective mAChR antagonists; atropine sulfate, tolterodine tartrate and propiverine hydrochloride, M2-selective antagonists; dimethindene maleate and methoctramine hemihydrate, M3-selective antagonists; darifenacin hydrobromide and 4-DAMP) on bladder overactivity induced by oxotremorine-M (Oxo-M; non-selective mAChR agonist). Intravesical administration of Oxo-M (200 μM) elicited bladder overactivity as evidenced by decreased intercontraction interval, bladder capacity and pressure threshold. These effects were blocked by intravesical administration of non-selective or M2-selective antagonists (30–60 μM) whereas M3-selective antagonists (150 μM) did not suppress the overactivity. When instilled intravesically by itself, none of antimuscarinic agents (non-selective, M2-selective or M3-selective antagonists) affected any cystometric parameters. The M2 mAChR subtype plays an important role in the local cholinergic modulation of bladder afferent activity that contributes to bladder overactivity in normal rats. Therefore, it is expected that antimuscarinic agents that have antagonistic activity against M2 mAChR can be more beneficial for the treatment of patients with overactive bladder if enhanced ACh mechanisms are involved in pathogenesis of overactive bladder.
登录
查看更多内容
影响因子:
2.1
作者:
Nishiguchi, J;Hayashi, Y;Yoshimura, N
通讯作者:
Yoshimura, N
影响因子:
3.6
作者:
Yoshimura, Naoki;Kaiho, Yasuhiro;Tyagi, Pradeep
通讯作者:
Tyagi, Pradeep
影响因子:
6.1
作者:
Bschleipfer, Thomas;Schukowski, Konstantin;Lips, Katrin S.
通讯作者:
Lips, Katrin S.
影响因子:
4
作者:
Fritz, N;Macrez, N;Morel, JL
通讯作者:
Morel, JL
影响因子:
5.3
作者:
Kullmann, F. Aura;Artim, Debra E.;De Groat, William C.
通讯作者:
De Groat, William C.